phenylalanyl-leucyl-arginyl phenylalaninamide has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
| Studies (phenylalanyl-leucyl-arginyl phenylalaninamide) | Trials (phenylalanyl-leucyl-arginyl phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-arginyl phenylalaninamide) | Studies (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Trials (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Recent Studies (post-2010) (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) |
|---|---|---|---|---|---|
| 40 | 0 | 0 | 3,412 | 41 | 631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baux, G; Fossier, P; Tauc, L | 1 |
1 other study(ies) available for phenylalanyl-leucyl-arginyl phenylalaninamide and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Activation of protein kinase C by presynaptic FLRFamide receptors facilitates transmitter release at an aplysia cholinergic synapse.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Aplysia; Calcium; Electrophysiology; Enzyme Activation; Isoquinolines; Neurotransmitter Agents; Oligopeptides; Parasympathetic Nervous System; Piperazines; Protein Kinase C; Receptors, Neurotransmitter; Receptors, Nicotinic; Synapses | 1990 |